文献速递肿瘤 PET/CT

前列腺癌[15O]H2O PET肿瘤灌注测量的可重复性

Repeatability of tumour perfusion measurement with [15O]H2O PET in prostate cancer.
PubMed 文献 · EJNMMI Res · 2026-01-08

参数图计算与VOI分析的重复性均为30%,ICC分别为0.89和0.91。纵向评估中变化超过30%可能代表肿瘤灌注的真实改变。

要点

  • 前列腺癌[15O]H2O肿瘤灌注测量重复性为30%,ICC为0.89–0.91。
  • 参数图与VOI分析两种方法性能相当。
  • 纵向评估中灌注变化超过30%可能反映真实变化。

核心结论

  • 局限性前列腺癌的[15O]H2O肿瘤灌注测量具有高可重复性,参数K1灌注图与VOI分析性能相当。

主要发现

  • [15O]H2O K1的重复性在参数图计算和VOI分析中均为30%。
  • 参数图计算的ICC为0.89,VOI分析的ICC为0.91。
  • 检测随时间20%相对变化的研究样本量10例患者应足够。

关键数值与推荐

  • 纵向评估中,灌注变化超过30%可能代表肿瘤灌注的真实改变,例如对特定治疗的反应。

临床怎么用

  • 纵向评估前列腺癌灌注变化时,超过30%的变化可考虑为真实改变而非测量误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumour perfusion is a universal cancer biomarker with potential value in characterising primary prostate tumours and longitudinal measurements for evaluation of treatment response. To evaluate whether a change in perfusion is significant, the reproducibility of the measurement must be known. [15O]H2O positron emission tomography (PET) is the gold standard for non-invasive quantitative perfusion imaging, however repeatability data on prostate cancer are currently unavailable. Hence, the aim of the present study is to determine the repeatability of [15O]H2O tumour perfusion in prostate cancer. RESULTS: Thirteen well-defined MRI PI-RADS lesions from ten patients were studied. The repeatability of [15O]H2O K1 was 30% using both parametric image calculation and volume of interest (VOI)-based analysis. Intraclass correlation coefficient (ICC) was 0.89 and 0.91 for parametric image calculation and VOI-based analysis, respectively. A study sample size of 10 patients should be sufficient for detecting a relative change of 20% over time. CONCLUSIONS: [15O]H2O tumour perfusion in localised prostate cancer can be measured with a high repeatability, showing comparable performance when using parametric K1 perfusion maps and VOI-based analysis. For longitudinal evaluation, changes above 30% are likely to represent actual changes in tumour perfusion, for example as response to a specific treatment.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Jochumsen MR, Sörensen J, Christensen NL, et al. Repeatability of tumour perfusion measurement with [15O]H2O PET in prostate cancer. EJNMMI Res. 2026. PMID: 41507573. doi:10.1186/s13550-026-01375-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。